Get started
Author

Kristine Karlsrud Berg

Observed names: Berg, Kristine Karlsrud, Kristine K. Berg
Institution: Sørlandet Sykehus
ORCID: 0009-0000-1684-9859
Observed ORCID: 0009-0000-1684-9859
OpenAlex ID: A5031212339
SARS-CoV-2 antibody persistence after five and twelve months: A cohort study from South-Eastern Norway
2022 · Marjut Sarjomaa, Lien My Diep, et al. · PLoS ONE · 14
PDF
Rituximab leading to an atypical presentation of neuroborreliosis and false negative serology
2023 · Åslaug Rudjord Lorentzen, Kristine Karlsrud Berg, et al. · Practical Neurology · 5
Towards shortening the duration of antibiotic therapy for Lyme borreliosis: a systematic review and meta-analysis
2025 · Alice Raffetin, Anna J. Henningsson, et al. · Infection · 4
Risk factors for SARS-CoV-2 infection: a test-negative case–control study with additional population controls in Norway
2024 · Marjut Sarjomaa, Chi Zhang, et al. · BMJ Open · 3
PDF
SARS-CoV-2-specific humoral immunity in a Norwegian cohort between 2020 and 2023
2025 · Marjut Sarjomaa, Kristine Karlsrud Berg, et al. · BMC Medicine · 2
PDF
Rapid laboratory diagnosis of urinary tract infection, with or without antibiotic decision support–a small pilot study investigating accuracy and clinical impact
2024 · Einar Nilsen, Kristine Karlsrud Berg, et al. · Apmis · 1
Neoehrlichiosis Causing Hemolytic Anemia in Patients Treated with Rituximab, Norway, 2024–2025
2026 · Martin Paulson, Christine Wennerås, et al. · Emerging infectious diseases
Prevalence of severe fatigue after SARS-CoV-2 infection in Norway: a prospective 2-year follow-up study
2026 · Kristine Karlsrud Berg, Marjut Sarjomaa, et al. · BMJ Open
PDF
Risk factors for COVID-19: A test-negative case-control study
2023 · Marjut Sarjomaa, Randi Eikeland, et al.
Works count: 14
Citation count: 29
H-index: 3
I10-index: 1
Year
Topic
Type